Schonfeld Strategic Advisors’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,053
Closed -$193K 2774
2025
Q4
$193K Sell
18,053
-1,138
-6% -$12.1K ﹤0.01% 1724
2025
Q3
$203K Buy
+19,191
New +$203K ﹤0.01% 1943

Other funds holding GPAT

Schonfeld Strategic Advisors's GPAT Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of GP-Act III Acquisition Corp (GPAT) in Q1 2026, closing a stake of 18,053 shares — an estimated $193K sold.

Schonfeld Strategic Advisors first reported a position in GPAT in Q3 2025 and held it in 2 quarters. The position peaked at $203K in Q3 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining GP-Act III Acquisition Corp position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 18,053 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $193K.
  • Schonfeld Strategic Advisors first reported a position in GP-Act III Acquisition Corp in Q3 2025 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's GP-Act III Acquisition Corp position peaked at $203K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.